Our highlighted selection of recent Covid-related case series or case reports from the scientific press for September 2022.
The annual societal cost of Parkinson's disease across Europe reached €22.8 billion in 2019 according to a new study within the EAN-led Cost of Illness in Neurology in Europe (COIN-Eu) initiative.
Latest Posts
-
-
EAN NewsBreaking newsCOVID-19COVID-19 Breaking News: Cross-Sectional Case Control Studies – September 2022
Our editors' pick of recent Covid-related cross-sectional case control studies from the scientific press for September 2022. -
With relatively few chances for EAN staff and members to meet in person, we decided to use this platform to present the team behind the scenes. This time it's Julia, Acting Head of the Scientific Dept, and Sara from the Industry Department. -
Brain HealthEAN NewsTop ArticlesSupport Call to European Commission for Thematic Network on Brain Health!
This week, the European Brain Council responded to the European Commission’s Call for Proposals on 2022 Thematic Networks, which invites health stakeholders to submit proposals for a new cycle of Thematic Networks, organised under the framework of the EU Health… Continue Reading -
A joint session between the International Parkinson and Movement Disorder Society and the EAN will be held on 16 September, during the MDS Congress. -
For the 9th Annual Congress of the European Academy of Neurology on July 1-4 we are heading to the grand and beautiful city of Budapest, Hungary, right in the heart of Europe. -
Executive PageEAN NewsFeatured SliderExecutive Page: Challenge of maintaining high standards is a privilege says incoming Education Committee Chair
New EAN Education Committee Chair, Irena Rektorova, introduces herself with an overview of recent and upcoming EAN educational initiatives. -
Paper of the MonthEAN NewsFeatured SliderResearch Papers of the Month: ‘Trial of Cinpanemab in Early Parkinson’s Disease’ and ‘Trial of Prasinezumab in Early-Stage Parkinson’s Disease’
This month we have selected two phase-2 trials investigating α-synuclein-binding antibodies as potential disease-modifying treatment of Parkinson’s disease. -
Paper of the MonthEAN NewsCOVID-19Featured SliderCovid-19 Paper of the Month: Risk of SARS-CoV-2 infection, hospitalization, and death for COVID-19 in people with Parkinson disease or parkinsonism over a 15-month period
Our authors of the month for September conclude that people with Parkinson's Disease and parkinsonism showed a higher risk of SARS-CoV-2 infection throughout the first 15 months of the pandemic. -
This September, EAN e-Learning is happy to highlight content on multiple sclerosis. In addition to four brand new episodes of eanCast: Weekly Neurology every Monday, several webcasts, guidelines, and interactive cases have been made openly available on the EAN Campus. -
EAN NewsEAN Congress newsTop ArticlesSpecial EAN issue of BrainMag features reports on EAN 2022 and more
A special EAN edition of German-language publication BrainMag was published in August, featuring reports from the EAN 2022 congress and an interview with the Editor-in-Chief of the EAN e-learning platform, eanCampus. -
The final EPICLUSTER meeting will take place on 29 September, in Brussels and online, under the heading 'Shaping the future of epilepsy research in Europe. -
EAN NewsEducation cornerJoint ERN-ERD free educational webinars on rare neurological and movement disorders
Three free educational webinars on rare neurological and movement disorders coming up in September, held jointly by the European Reference Network for Rare Neurological Diseases (ERN-RND) and EAN. -
Why neurology? By the end of EAN 2022 the answer was crystal clear for EAN Student Member, Stella Goeschl, who tells us all about her experience at our recent annual congress. -
Our highlighted selection of Covid-related Literature Reviews from the scientific press for August 2022.